(Q37737385)

22 August 2017

1 reference

title

Neurodegenerative disease-specific induced pluripotent stem cell research (English)

1 reference

22 August 2017

1 reference

Haruhisa Inoue

1

1 reference

22 August 2017

language of work or name

English

0 references

publication date

24 April 2010

1 reference

Experimental Cell Research

22 August 2017

published in

1 reference

22 August 2017

volume

316

1 reference

22 August 2017

issue

16

1 reference

22 August 2017

page(s)

2560-2564

1 reference

A network dysfunction perspective on neurodegenerative diseases

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.022

A century-old debate on protein aggregation and neurodegeneration enters the clinic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.022

Cell death in the nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.022

ALS: astrocytes move in as deadly neighbors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.022

Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.022

ALS: a disease of motor neurons and their nonneuronal neighbors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.022

Therapeutic targets for amyotrophic lateral sclerosis: current treatments and prospects for more effective therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.022

Programmed cell death in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.022

Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.022

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.022

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.022

Strategies and new developments in the generation of patient-specific pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.022

Induced pluripotent stem cells from a spinal muscular atrophy patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.022

Disease-specific induced pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.022

Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.022

Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.022

Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.022

Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.022

Generation of pluripotent stem cells from patients with type 1 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.022

Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.022

Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.022

Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.022

Onset and progression in inherited ALS determined by motor neurons and microglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.022

Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.022

Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.022

Transgenic Small Interfering RNA Halts Amyotrophic Lateral Sclerosis in a Mouse Model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.022

Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.022

Wild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.022

Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.022

Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.022

Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.022

Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.022

Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.022

Interactions between Purkinje neurones and Bergmann glia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.022

Bergmann glia expression of polyglutamine-expanded ataxin-7 produces neurodegeneration by impairing glutamate transport.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.022

ALS model glia can mediate toxicity to motor neurons derived from human embryonic stem cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.022

Technical challenges in using human induced pluripotent stem cells to model disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.022

10.1016/J.YEXCR.2010.04.022

7 January 2021

Identifiers

DOI

1 reference

22 August 2017

1 reference